Clinical Trial

Clinical Evaluation of a Novel Trifocal IOL

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to understand the visual outcomes of the investigational intraocular lens (IOL) Model LPYWT0 when compared to the commercially marketed Clareon PanOptix Pro IOL Model PXYWT0.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-08; most recent amendment 2026-07-07.
Trial Details
NCT Number NCT07587138
Lead Sponsor Alcon Research
Conditions Aphakia, Cataract
Enrollment 66 participants
Start Date 2026-10
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-08